Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia
Hämostaseologie · 01.06.2026 · 46 (03) · 206-214
DOI: 10.1055/a-2411-7416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.06.2026. Verfasst von Christian Pfrepper und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany. Hauptthemen laut MEDLINE: Factor VIII, Hemophilia A, Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Prophylaxis is the standard of care for patients with severe hemophilia, patients with moderate hemophilia, or those with another congenital bleeding disorder that is associated with a severe bleeding phenotype and/or a high risk of spontaneous life-threatening bleeding. Patients with nonsevere hemophilia (factor VIII [FVIII] ≥ 1%) may also have a bleeding phenotype that requires prophylaxis. To date, however, there are no clear criteria as to when prophylaxis is indicated in these patients. Also, the term “severe bleeding phenotype (SBPT)” is neither included in the definitions of the International Society on Thrombosis and Haemostasis (ISTH) nor specified in the World Federation of Hemophilia (WFH) guidelines. Based on our personal experience and available evidence, we propose the criteria we use to define an SBPT and when we consider offering prophylaxis in patients with nonsevere hemophilia. Our proposals can be the basis for discussions in the community about the assessment of SBPT and the initiation of prophylaxis in patients with nonsevere hemophilia without inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany.
- Hemophilia Centre Rhein Main (HZRM), Frankfurt, Germany.
- Vivantes Klinikum im Friedrichshain, Berlin, Germany.
- Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
- Pediatric Thrombosis and Hemostasis Center, Pediatric Hemophilia Center, Dr. von Hauner Children's Hospital, LMU Munich, Germany.
Zitieren
APA
Pfrepper, C., Ettingshausen, C. E., Klamroth, R., Oldenburg, J., & Olivieri, M. (2026). Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia. Hämostaseologie, 46(03), 206-214. https://doi.org/10.1055/a-2411-7416
Vancouver
Pfrepper C, Ettingshausen CE, Klamroth R, Oldenburg J, Olivieri M. Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia. Hämostaseologie. 2026;46(03):206-214. doi:10.1055/a-2411-7416
BibTeX
@article{Pfrepper2026,
author = {Pfrepper, Christian and Ettingshausen, Carmen Escuriola and Klamroth, Robert and Oldenburg, Johannes and Olivieri, Martin},
title = {Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia},
journal = {Hämostaseologie},
year = {2026},
volume = {46},
number = {03},
pages = {206--214},
doi = {10.1055/a-2411-7416}
}
EUVIMED